[HTML][HTML] Triple‑negative breast cancer therapy: Current and future perspectives

KA Won, C Spruck - International journal of …, 2020 - … .spandidos-publications.com
Triple‑negative breast cancer (TNBC) accounts for 10‑15% of all breast cancer cases.
TNBCs lack estrogen and progesterone receptors and express low levels of HER2, and …

Basics of androgen synthesis and action

RN Elzenaty, T Du Toit, CE Flück - Best Practice & Research Clinical …, 2022 - Elsevier
Androgens are essential sex steroid hormones for both sexes. Testosterone (T) is the
predominant androgen in males, while in adult females, T concentrations are about 15-fold …

A new old target: androgen receptor signaling and advanced prostate cancer

D Westaby, MLD Fenor de La Maza… - Annual review of …, 2022 - annualreviews.org
Owing to the development of multiple novel therapies, there has been major progress in the
treatment of advanced prostate cancer over the last two decades; however, the disease …

Androgen receptor function and targeted therapeutics across breast cancer subtypes

EA Kolyvas, C Caldas, K Kelly, SS Ahmad - Breast Cancer Research, 2022 - Springer
Despite significant progress in breast cancer (BC) therapy, it is globally the most commonly
diagnosed cancer and leads to the death of over 650,000 women annually. Androgen …

Oridonin suppresses gastric cancer SGC‐7901 cell proliferation by targeting the TNF‐alpha/androgen receptor/TGF‐beta signalling pathway axis

S Gao, H Tan, D Li - Journal of Cellular and Molecular Medicine, 2023 - Wiley Online Library
Statistics provided by GLOBOCAN list gastric cancer as the sixth most common, with a
mortality ranking of third highest for the year 2020. In China, a herb called Rabdosia …

The role of androgens in women's health and wellbeing

VE Bianchi, E Bresciani, R Meanti, L Rizzi… - Pharmacological …, 2021 - Elsevier
Androgens in women, as well as in men, are intrinsic to maintenance of (i) reproductive
competency,(ii) cardiac health,(iii) appropriate bone remodeling and mass retention,(iii) …

Beyond proteolysis-targeting chimeric molecules: designing heterobifunctional molecules based on functional effectors

L Hua, Q Zhang, X Zhu, R Wang, Q You… - Journal of Medicinal …, 2022 - ACS Publications
In recent years, with the successful development of proteolysis-targeting chimeric molecules
(PROTACs), the potential of heterobifunctional molecules to contribute to reenvisioning drug …

Mechanism insights of curcumin and its analogues in cancer: An update

P Joshi, K Verma, D Kumar Semwal… - Phytotherapy …, 2023 - Wiley Online Library
Cancer is the world's second leading cause of mortality and one of the major public health
problems. Cancer incidence and mortality rates remain high despite the great …

N6-methyladenosine (m6A)-mediated lncRNA DLGAP1-AS1enhances breast canceradriamycin resistance through miR-299-3p/WTAP feedback loop

T Huang, L Cao, N Feng, B Xu, Y Dong, M Wang - Bioengineered, 2021 - Taylor & Francis
Chemotherapy resistance is identified as an obstacle for breast cancer (BC) therapy, and,
besides, increasing evidence indicates that long-noncoding RNAs (lncRNAs) participate in …

Invasion and metastasis as a central hallmark of breast cancer

T Saha, J Solomon, AO Samson… - Journal of Clinical …, 2021 - mdpi.com
Hanahan and Weinberg introduced the “hallmarks of cancer” and typified essential
biological abilities acquired by human cancer. Since then, a growing understanding of …